United Health Products Inc (PK) (UEEC) News

Trying wash trading to look like interest again? Lots of beneficial ownership shenanigans as usual. Tax write offs anyone?

Looks like the CEO once again has gone M.I.A. That is usually followed by more crap news. So far, they still haven't been approved for the new surgeries from the incompetent and corrupt FDA. I have heard nothing about securing new financing not using White Lion or getting up listed. So as usual, Thom is accomplishing almost nothing and is trying to hide again which he said he wouldn't. He makes it harder and harder to believe with his stupidity.

trusttheman
Re: RetDrug post# 14018
Monday, September 30, 2024 2:17:27 PM
Post# 14019 of 14283
"Personally, I think Thom is on the way out. He sold his soul to White Lion and crossed the wrong people. I expect he might last a month more before his incompetent behind is kicked to the curb."
trusttheman
Re: Hoonigan post# 14070
Friday, October 11, 2024 2:32:14 PM
Post# 14071 of 14283
"Has to do more that Thom is incompetent and should have been fired over two years ago. Something I expect to happen in the very near future. This buffoon had every chance to do his job but obviously can't. Like I said before. When the massive shareholders think you are inept, it's over for you."
Month? Near future? How did this bullshit work out for you? Same as all of the other bullshits? I could spend the rest of 2025 digging up these bullshits. ROTFLMAO

Problem Jimmy is the FDA is totally corrupt. This last clinical trial crap stamps that. At least probably half of the FDA will be fired and rightly so. That could be a pro or con. Depending on how you look at it. They put their stamp of approval on this product when they declared it superior to the pile of crap industry leader. Then, backed it up with total corruption stalling over and over and over again. Hoping the company would go bankrupt. Crap like that is why most of them will be out of a job soon after January 20th. If they can pull this off and J&J doesn't get the product which I pray they don't. Watch J&J's band-aid market go to crap in a couple of years. That will bring great joy to me. What a pleasure it will be to use a band-aid that stops bleeding in seconds, helps the wound heal 5 times faster and not have to use 10 band-aids for a decent cut like you have to with J&J's crappy band-aids.

Happy New Year my friend.. All the best

Great post Jimmy.. happy new year

Happy New Year to all..
First this will be the year that this happens..
Second nobody knows what’s to come on a buyout or pps basis… We’re heavily shorted and if we get uplisted and we get some real strong news… boom this will happen fast.. nobody knows what is to come but there will be something coming this year for sure.. many people have a lot riding on this coming to fruition and have much more to gain by It happening rather than staying where we are now.. many people have a lot of time invested in this

I have owned this stock for so many years. I bought it on a whim at .09 per share. The fact that I state the truth does not make me what you say. You and many others have be trumpeting this stock for years. It will be bought out at ridiculous amounts. I hold it because I have nothing to lose in the stock, but am realistic on a potential buyout.

Happy new year to all, 2024 a lost year for this stock, my wish amongst others,,is for management to get their shit together and do what they promised on the last presser.
Ceo has been horrible, he needs to step up and do his job,,get this company and its shareholders what we all know is possible.
1. Get fda to approve ide.
2.start surgeries as soon as possible.
3. Get uplisting approved.
4.secure financing
5.add experienced board members.
6. Get fda approval.
7.sell the company for cash or stock.

Might be dreaming, if I forgot something, oh well. Hopefully selling is over, losses taken , we will see over the coming days.

God bless and happy new year

Happy new year to all, 2024 a lost year for this stock, my wish amongst others,,is for management to get their shit together and do what they promised on the last presser.
Ceo has been horrible, he needs to step up and do his job,,get this company and its shareholders what we all know is possible.
1. Get fda to approve ide.
2.start surgeries as soon as possible.
3. Get uplisting approved.
4.secure financing
5.add experienced board members.
6. Get fda approval.
7.sell the company for cash or stock.

Might be dreaming, if I forgot something, oh well. Hopefully selling is over, losses taken , we will see over the coming days.

God bless and happy new year

Get lost. Another paid of. Ihub troll.

Last second tax write off sales.

Special note on a 12/18 SEC posting.....The Wendy Bepolate Irrevocable Trust was in this Schedule 13D filing.
7.2 % is a sizeable influence to the future direction of voting shares. Indication of a coming uplisting?
$5-$10+

https://app.quotemedia.com/data/downloadFilin...2024-12-19

Merry Christmas!

In my world of investing in stocks see stocks rise and fall on earnings and revenue. My concern is clear, a stock does not tank, as this has done, with the results it received from the trials, unless there is no confidence that the product will actually come to market. If I was an employee or management I would be buying this hand over fist unless there is not alot of hope it will actually come to market. I do not sell because this has become play money. If it does well great. If not this will not have any impact on my portfolio. Buy real stocks like AAPL, MSFT or QCOM. I have owned forever and will hope for the best ($3 per share)

Thanks Hoonigan. I’m not looking to debate your formula. However, please keep in mind that UHP is applying for a PMA for Gauze only.
Gauze makes up 25% of the Hemostatic market.
The rest is gels, powders etc.
The entire Hemostatic Gauze market is approximately $1 billion per year at this time.

BTW, Kevin O’Leary owns a ton of JnJ stock and it’s one of his top 10 picks. Maybe he should buy up some UEEC while he’s at it.

Made a mistake should be --- If the UEEC products get 10% of the market over the next five years that is $3 billion and they have 25% earning the company is worth $750 Million. Based on the standard 5 times earnings company cost valuation that the great Kevin O'leary uses, the stock is worth $3 a share. 5% of the market it is worth $1.5 (based 250 million shares). The missing facts are percentage of earnings and market share. If you have those to facts you have a solid valuation estimate.

Wow 7 million shares sold in the last month 57% were long holds diluting the market with shares driving down the stock price to these crazy levels. I keep buying all I can and feel liking I am stealing shares but someone needed some cash or end of year right off really bad. We all know who sold 10 million shares and was a shame they had to sell them. I am positive UEEC is rounding up some serious investors for the new year.

Surgicel Absorbable Hemostat Market Size was valued at USD 4 Billion in 2023 and is expected to reach USD 9.7 Billion by 2031
Break out that calculator and visor to double check me, I did this really quickly in my head without coffee and with a flue bug! feel free to start slinging mud, I have my roll off goggles and helmet on.

Here is a link to a recent market analysis (link!!) Surgicel Absorbable Hemostat Market Size and Projections

If the UEEC products get 10% of the market over the next five years that is $3 billion and they have 25% earning the company is worth $1.5 billion. Based on the standard 5 times earnings company cost valuation that the great Kevin O'leary uses, the stock is worth $3 a share. 5% of the market it is worth $1.5 (based 250 million shares). The missing facts are percentage of earnings and market share. If you have those to facts you have a solid valuation estimate.

Let the mud fly!!!

Hopefully RFK and DOGE can rid the FDA of its in-efficiency and corruption that has been pervasive in the pharmaceutical industry for years! In the meantime here we are!
https://www.greenlight.guru/blog/fda-medical-device-approval-process
$5-$10+

If there is one iota of truth in what you state; please state why this piece of crap can't even sell over the counter in any country, anywhere on Earth. The FDA can only limit sales in the United States. It has been over a decade. Where are the over the counter sales?

"FIRST CLAIM FOR RELIEF
Violations of Exchange Act Section IO(b) and Rule 10b-5 Thereunder
(UHP and Beplate)
SECOND CLAIM FOR RELIEF
Violations of Exchange Act Section I0(b) and Rules IOb-S(a) and (c) Thereunder
(Schiliro)
THIRD CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section lO(b) and Rule 10b-5(b)
(Schiliro)
FOURTH CLAIM FOR RELIEF
Violations of Securities Act Section 17(a)
(All Defendants)
FIFTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a), 13(b)(2)(A) and 13(b)(2)(B)
of the Exchange Act and Rules 12b-20, 13a-1 and 13a-13 Thereunder
(UHP)
SIXTH CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section 13(a),
13(b)(2)(A), 13(b)2)B), and Rules 12b-20, 13a-1 and 13a-13
(Beplate and Schiliro)
SEVENTH CLAIM FOR RELIEF
Violation of Section 13(b)(5) of the Exchange Act and Exchange Act Rule 13b2-1
(Beplate and Schiliro)
EIGHTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a) and Rule 13a-14 Thereunder
(Beplate)
NINTH CLAIM FOR RELIEF
Violations of Rule 13b2-2 of the Exchange Act
(Beplate and Schiliro)
TENTH CLAIM FOR RELIEF
Violations of Sarbanes-Oxley Act Section 304(a)
(Beplate)
ELEVENTH CLAIM FOR RELIEF
Violations of Exchange Act Section 16(a) and Rule 16a-3 Thereunder
(Beplate)"
https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf

Please stop lying. It helps no one.

“However, they put their name on Hemostyp when they declared it superior to the industry leader.”

And using this lie to support a false statement:

“They wouldn't do that if they weren't eventually going to approve it.”

I know this is just a message board and anything goes, but blatant lies have to be called out.

My hope is that UHP is on the right path going forward. But all these conspiracy theories, combined with lies are so unfortunate.

Hopefully, he is done posting in 2024.
If that’s the case, I look forward to reading the board in 2025 , when there are some REAL events to comment on.

The one thing I can't stress enough is this from what I've heard from people who have used the band-aids. If you use one, you will never go back to the J&J crap bandages again. Essentially, they are worthless compared to the Hemostyp band-aid. Then of course you get into all the surgeries that will be using Hemostyp which will become the standard of care the second they are approved which we all hope will happen. All these delays are happening for a reason. Some will blame the company for the delays. I'm sure they could have done some things differently. However, make no mistake. The corrupt FDA is nothing but a puppet for J&J. That is one huge reason the new administration under Trump is going to clean house on them. J&J's bread and butter has always been band-aids. When people find out they have to use one Hemostyp band-aid, maybe a second if the cut gets wet instead of 10 to 15 J&J band-aids and the wound heals 3 to 4 times faster with a hemostyp band-aid, it causes extreme fear for even the biggest pharm company out there. They can say whatever they want. J&J is afraid. No matter now small the possibility is that they might not be able to obtain UEEC's product. They're afraid. The last move the FDA pulled proves that. As I said before. Absolute corruption asking for more abdominal surgeries when you had 4 years to do so. It's a slimy, corrupt tactic that they can get away with because of the simple fact we are a small OTC company. However, they put their name on Hemostyp when they declared it superior to the industry leader. They wouldn't do that if they weren't eventually going to approve it. If these delays weren't so painful I would be laughing my ass off that a little OTC company with a game changing product is scaring the biggest bully pharm company on the planet. J&J always talks tough. Saying they won't chase something. Historical, they always overpay. Just imagine what they will pay for a product that not only will eliminate Surgicrap but could potentially wipe out their band-aid market.

Agree, wave and good point!. I don't think we will see any comment from the FDA other than an approval or denial when they finally feel they have enough information to make that decision.

Thanks GR$. Yes, UHPs clinical trials absolutely showed superiority. That is definitely a fact.
This PR wisely notes that the UHP team made this clear to the FDA in their discussion.
That was smart. In the quote you have provided “ the company (UHP)noted the results of its clinical trial.” That is great.

In no way does this indicate that the FDA has given Hemostyp (CelluStat) a superior rating.

Per UEEC's press release. They were the one to first use "superiority"

During the discussion, the company noted the results of its clinical trial involving 232 patients (of whom 118 were treated with its hemostatic gauze) that showed both non-inferiority and superiority for time to hemostasis using CelluSTAT (fka HemoStyp) relative to the standard of care and showed no evidence of heterogeneity of results across procedure categories, surgeons, or clinical sites, indicating both poolability and generalizability of study results.

I think we have more opinions than facts.. fact is we don’t have the information from the company that we need entirely and we are going off of hypotheses and I do think some of us have aspirations that are a bit too high but then again on this market nobody knows anything., I’ve seen totally useless pieces of shit run for no reason at all.. let’s hope we go the right way and get the proper fda approval because that is how I would like to see it play out.. no scams no pumps no stories.. just facts and an approval that makes us class 3 because that is what we really need

I almost made it to the end of 2024 without engaging with any more of this person’s posts, but this is so inaccurate that I just can’t help myself.

1. When did FDA give Hemostyp a superior rating. Trust says this twice.
“ The FDA as I said gave this a superior rating.”

2. DBnews was not “completely wrong “. Hemostyp (aka CelluStat) is a class 1 device that could be sold in retail.

3. It is not a class 3 device until it gets approved. It is a class 1 device. There was potential in this market but UHP decided to go all in on the PMA.

4. It didn’t go to $2.45 due to a “fast track announcement.” It was an unprecedented surge based on pumpers and MM creating a huge Shorting opportunity (remember White Diamond)

5. $20-30 per share. Sounds good, but just a made up number. DB’s numbers are far more realistic.

6. His Bandaid rant is hilarious. But he sure talks like an expert, though he has never bought or used the “band-aid aspect” of this product.” Somehow he knows one would require up to 15 more band aids. Why didn’t he spend $20 and buy the superior product? They were available to the general public yet he never bought (or used) a product he’s invested in, yet he boldly states “ The band-aid aspect of this product is going to put J&J in serious trouble if they don't get the product”

7. “ The projected current value of the company when it was appraised was 4 to 900,000 million.”
4 to 900,000 million. What the heck.
$900,000,000,000.00
That’s just wild.

8. The FDA conspiracy is odd. I’ll leave it at that.

Hoping for the best in 2025. To the posters asking intelligent questions and/or attempting to add a rational voice to this board, keep it up Please. Trust me, there are readers here that really do want to have those discussions. It’s just hard to get berated but the angry man.

Thank you for the reply I appreciate the info.. definitely good news.. let’s hope we’re on the way

Nice post.. very informative

The opinion was from a medical professional who is the smartest person I know. I think there has been commentary from board members who have stated that the approvals for Dental and Vets. were in place. A Annual Report a couple years back actually showed a $35,000 product sale for the only income stream I am aware of. I am not sure but the 35K sale of product may have been to a Dental operation. It was my understanding that these two approvals were obviously different from the in human surgical uses. IMO if they have these two approvals in place; the bottom worst case is far above the .05 cent range we now see. But I agree; the real hope is for the elements of our government not functioning in the public interest to be gone. Hope is in sight. Could we add a little "Joy"? LOL.

Completely incorrect DBNews. This is a class 3 device. Almost impossible to get approved. They were already given a superior rating by the FDA to the only competitor for class 3 on the market. Which by the way is a pile of crap and was never FDA approved. Grandfathered in. I would be shocked if it didn't go to 3 to 5 dollars on approval. It went to $2.45 when they announced they were on the fast track program for the FDA. Which by the way obviously was a load of crap from the corrupt FDA who will soon have over half its criminal employees fired. I said from the beginning. 20 to 30 dollars if they get approval and sell the company. 4 to 6 billion for this product is fly sh!t for a major pharma company that gets this product. They will make that back in the first couple years. Oh and by the way. The band-aid aspect of this product is going to put J&J in serious trouble if they don't get the product. I know people that have used them. You use one of this companies band-aids. Stops bleeding. Heals the cut much faster. You don't use 7 to 15 more like you do with the regular band-aid crap. Believe me. J&J knows this. You are kidding yourself if you don't think they have stalled approval on this with the FDA. Their band-aid market will suffer massive losses to Hemosytp band-aids. Don't be fooled by the current share price. It's what happens when the FDA is corrupt, uses stalling techniques and the stock is on the pinks being heavily shorted. The FDA as I said gave this a superior rating. They can't stall forever. The projected current value of the company when it was appraised was 4 to 900,000 million. Sales price usually goes 6 to 8 times that. 4 dollar a share for each billion. 2 dollars a share would be if they couldn't get this to the finish line approval wise. Like I said. Take comfort in that the FDA firings are coming.

What is your opinion of the source that shared this opinion?? Obviously I would love for it to be the case because it’s progress and any progress is welcomed.. thanks in advance

I had an opinion stated to me that the FDA approvals already in place for Vet. and Dental usages were in the worst case of
some reasonable value. That seems logical as a worst case. Any opinions out there on this assumption??

New to board. Been watching board for many years listening to all your opinions on this stock. I bought in at the beginning at .09 per share (about 40000) shares. Sold about 15000 over the years at .65 to .75. Got all my money back as the original purchase was a whim. I have seen all the speculations about a pot of gold at the end of the rainbow. I saw the stock hit over $2.00 per share, was thrilled, only to see it drop. Now its below what I paid for it so many years ago. Any idiot who thinks this is going to $5 or $10 per share on a buyout is not a real investor. If the FDA ever approves this, and I mean ever, we would be lucky to get $2.00. That would be OK for me. Stop saying it is worth so much.

Looks like some shareholders are throwing in the towel.Got a link for that?
It's not for the faint of heart having to wait for the corrupt FDA...The FDA isn't corrupt,,, yet. It's their job and they do it well. The FDA waits on the uhp corp to deliver the proper paperwork. It's on the scam uhp to deliver the goods, they're the ones to blame, not the FDA. It's never been the FDA. Constant repeating it's someone else's fault doesn't make it true.

Just shows the company is a scam.

Nasdaq has never been considered ,,otcqb is what they have filed forThen that is NOT an uplisting. It is a forever pump lie for ceo's to claim they are uplisting when it's only paying a higher fee to otcm advertising service to get new 'initials' added to their name. Junk talk. Like this junk stock.

We have no choice but to wait at this point we’re this deep might as well go all the way… but about yesterdays posts.. we’re hardly heavily shorted no question

Looks like some shareholders are throwing in the towel. It's not for the faint of heart having to wait for the corrupt FDA to give up with their nonsense. I can wait a little longer.

Thanks for your work Trust! It its any consolation the short bashers only bash good stocks!
$5-$10+

You can see here the way this stock is shorted and has been for a very long time.

https://www.otcshortreport.com/company/UEEC

Heads must roll!!!!

Wow someone needs some cash before Christmas that just got a ton of shares to sell at these low bargain prices and volume. It is a shame that they have to sell and dilute the market to get some cash. But it is a Great Christmas present buying opportunity! I will keep buying all day long at $.061 what a steal.

Looks like robot Santa loaded his sleigh up with stock too and is out doing some shenanigans!

Very interesting I didn’t know that again thanks for the info and let’s hope this is moving us toward the uplisting..

Actually closer to 35 then he gave 1+ million shares back to the company in partial payment of his SEC ruling. He then put 18 million into a grantor trust with a trustee empowered to control the trust assets so he basically divested himself of all but the 6.7 million.
Interesting!

Thank you

Based on my experience, I'm guessing this was done to clarify some questions related to the OTCQB uplift filing. This would also explain why something that normally takes 6 -8 weeks still hasn't been completed.

Thoughts?? Didn’t he own like 30 million + in shares?

Former CEO filed and SEC required statement to indicate his percentage of ownership decreased. Not sure what the overall implication is but he now only controls 6,700,000 shares of UEEC.

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318767261&type=HTML&symbol=UEEC&cdn=bb1a4e05e3671da42927a9f4a730762f&companyName=United+Health+Products+Inc&formType=SC+13D%2FA&formDescription=%5BAmend%5D+General+statement+of+acquisition+of+beneficial+ownership&dateFiled=2024-12-04

As usual very well said

As usual very well said